April 14 (Reuters) - Johnson & Johnson:
* French European Affairs Minister Clement Beaune told France 2 TV on Wednesday that Europe's EMA health regulator was likely to issue new guidance on Johnson & Johnson's COVID vaccine on Wedneday.
* U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson's COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic. Further company coverage: (Reporting by Sudip Kar-Gupta)
Our Standards: The Thomson Reuters Trust Principles.